HOME >> MEDICINE >> NEWS
Rise in ICSI cycles suggests infertility could be affecting more men than women

ditional IVF required more than half a million sperm for a good chance of fertilisation; ICSI requires just one sperm to be injected into each egg. Sperm dysfunction may also be overcome by ICSI since more than 50% of eggs usually fertilise normally, regardless of the quality of the sperm injected, provided it is viable.

"It is also possible that as ICSI techniques have improved, patients and doctors are voting with their feet and using it in ever increasing numbers, despite any residual fears about its safety and the health of ICSI babies," said Dr Nyboe Andersen.

The quality and efficacy of assisted reproduction technology (ART) in Europe is steadily improving according the 2002 figures.

Chairman of the committee, Professor Karl Nygren, Associate Professor of Obstetrics and Gynaecology at Sofiahemmet Hospital in Stockholm, Sweden, said: "During the six year period from 1997 to 2002 there has been a minor decline in twin birth rates, and triplet birth rates have fallen from 3.6% to 1.3% after IVF and ICSI. For the first time we are seeing the impact of patients and doctors choosing to implant only one embryo [elective single embryo transfer eSET], and in 70% of all transfers only one or two embryos were transferred. However, despite the reduction in the numbers of embryos transferred in one cycle, the pregnancy rate has remained the same or, in fact, in some countries actually improved.

"This is good news for mothers and babies, because multiple births are dangerous for both and can cause congenital problems in the offspring."

Dr Nyboe Andersen added: "New data from Finland and Sweden have demonstrated that single embryo transfer can be introduced on a national level without a decline in the ongoing pregnancy rate, but with a marked reduction in the multiple pregnancy rates. More than 50% of cycles in Finland and Sweden are single embryo transfer and the multiple delivery rate is approximately only 10% compared with ab
'"/>

Contact: Mary Rice
mary@mrcommunication.org
European Society for Human Reproduction and Embryology
22-Jun-2005


Page: 1 2 3

Related medicine news :

1. Web model of influenza-host lifecycles will aid scientists in creating anti-viral drugs
2. Study suggests loss of 2 types of neurons -- not just 1 -- triggers Parkinsons symptoms
3. Wheres the beef? Not enough of it is on elders plates, muscle-metabolism study suggests
4. Study suggests nonpharmaceutical interventions may be helpful in severe influenza outbreaks
5. Study suggests antithrombotics cause more intracerebral hemorrhagic stroke deaths in over-75s
6. Penn study on lung-infecting bacterial enzyme suggests new approach to cystic fibrosis treatment
7. Study suggests use of stem cell transplantation is beneficial treatment of type 1 diabetes
8. Shrug off shoulder surgery myth, study suggests
9. Study suggests wearing no-line bifocals slows myopia progression in some children
10. A year of added life more valuable for the young, study suggests
11. Do specialty heart hospitals drive up heart care use? Study suggests the answer is yes

Post Your Comments:
(Date:7/24/2014)... (PRWEB) July 24, 2014 The ... Association (AOA) and the Entertainment Industries Council (EIC) ... TV series American Horror Story on a first-of-its-kind ... the dramatic realities of illegal and unsafe lens ... which has already reached tens-of-thousands, is now releasing ...
(Date:7/24/2014)... -- A new formulation of a powerful narcotic painkiller ... drug has been approved by the U.S. Food and ... Purdue Pharma, the pill is a combination of the ... euphoric effects of oxycodone. The naloxone is only activated ... according to the FDA. While Targiniq has only ...
(Date:7/24/2014)... 17, 2014, Cleveland: Could the body,s own immune system ... associated with conditions like chronic epilepsy, Alzheimer,s dementia and ... study published online by PLOS ONE . , ... known as S100B, which serves as a biomarker for ... brain and spinal column. However, following a brain injury, ...
(Date:7/24/2014)... July 24, 2014 National Analysts Worldwide, ... that it will operate globally under the name, ... a woman-owned Employee Stock Ownership Plan (ESOP) organization led ... McDonald, Ph.D . The firm guides market strategy ... analytics. , Said McDonald, “We wanted our name ...
(Date:7/24/2014)... The report, “Feed Palatability Enhancers & Modifiers ... Poultry, Cattle, Pets, Aquaculture, and Others) - Global Trends ... palatability enhancers & modifiers market with an analysis and ... of types of feed flavors, sweeteners, and text rants. ... spread through 275 pages and in-depth TOC on "Feed ...
Breaking Medicine News(10 mins):Health News:Optometric Professionals Team with Hollywood for Second Installment of Video Campaign 2Health News:Optometric Professionals Team with Hollywood for Second Installment of Video Campaign 3Health News:Optometric Professionals Team with Hollywood for Second Installment of Video Campaign 4Health News:FDA Approves Hard-to-Abuse Narcotic Painkiller 2Health News:Immune response may cause harm in brain injuries, disorders 2Health News:National Analysts Worldwide Announces a Change of Name to NAXION 2Health News:National Analysts Worldwide Announces a Change of Name to NAXION 3Health News:Feed Palatability Enhancers & Modifiers Market Worth $3172.6 Million by 2019 - Report by MarketsandMarkets 2Health News:Feed Palatability Enhancers & Modifiers Market Worth $3172.6 Million by 2019 - Report by MarketsandMarkets 3Health News:Feed Palatability Enhancers & Modifiers Market Worth $3172.6 Million by 2019 - Report by MarketsandMarkets 4
(Date:7/24/2014)...  Blueprint Medicines (Blueprint), a leader in discovering highly ... announced the appointment of Jeffrey Albers as ... Algeta ASA, where he served on the executive management ... Bayer. Mr. Albers succeeds Alexis Borisy , co-founder ... Rock Ventures, who will remain an active member of ...
(Date:7/24/2014)... SAN DIEGO , July 24, 2014 /PRNewswire/ ... the industry leader in bioactive lipid-targeted therapeutics, reported ... trial where ASONEP™ is being investigated as a ... patients that have failed at least one therapy ... and no more than one mTOR inhibitor (e.g., ...
(Date:7/24/2014)... 24, 2014  Market Diagnostics International LLC ("MDxI") ... LabFile , a data resource that sets a ... universe and identifying target In Vitro Diagnostics (IVD) ... that provides IVD manufacturers with accurate and comprehensive ... clear and consistent definitions of laboratory categories and ...
Breaking Medicine Technology:Blueprint Medicines Appoints Jeffrey Albers as Chief Executive Officer 2Lpath Reports Interim Data From Phase 2a Study for Anti-Cancer Drug, ASONEP 2Lpath Reports Interim Data From Phase 2a Study for Anti-Cancer Drug, ASONEP 3Lpath Reports Interim Data From Phase 2a Study for Anti-Cancer Drug, ASONEP 4MDxI Launches Data Resource Setting New Standard for Defining and Targeting US Clinical Laboratory Universe 2
Cached News: